{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:46:54Z","timestamp":1790344014357,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T00:00:00Z","timestamp":1499817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/leu.2017.220","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T06:40:48Z","timestamp":1499841648000},"page":"438-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Involvement of MAF\/SPP1 axis in the development of bone marrow fibrosis in PMF patients"],"prefix":"10.1038","volume":"32","author":[{"name":"on behalf of the AGIMM (AIRC Gruppo Italiano Malattie Mieloproliferative) Investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ruberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-284X","authenticated-orcid":false,"given":"P","family":"Guglielmelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Rontauroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Tavernari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Norfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Pennucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Corbizi","family":"Fattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mannarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Bartalucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Elli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Avanzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Salmoiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Zini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Salati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Prudente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Passamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Tagliafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Vannucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0660-6110","authenticated-orcid":false,"given":"R","family":"Manfredini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,12]]},"reference":[{"key":"BFleu2017220_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.blre.2016.06.001","volume":"30","author":"T Barbui","year":"2016","unstructured":"Barbui T, Thiele J, Gisslinger H, Finazzi G, Vannucchi AM, Tefferi A . The 2016 revision of WHO classification of myeloproliferative neoplasms: clinical and molecular advances. Blood Rev 2016; 30: 453\u2013459.","journal-title":"Blood Rev"},{"key":"BFleu2017220_CR2","doi-asserted-by":"publisher","first-page":"415024","DOI":"10.1155\/2015\/415024","volume":"2015","author":"C Desterke","year":"2015","unstructured":"Desterke C, Martinaud C, Ruzehaji N, Le Bousse-Kerdiles MC . Inflammation as a keystone of bone marrow stroma alterations in primary myelofibrosis. Mediat Inflamm 2015; 2015: 415024.","journal-title":"Mediat Inflamm"},{"key":"BFleu2017220_CR3","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1186\/1755-1536-5-S1-S20","volume":"5","author":"MC Le Bousse-Kerdiles","year":"2012","unstructured":"Le Bousse-Kerdiles MC . Primary myelofibrosis and the \u201cbad seeds in bad soil\u201d concept. Fibrogenesis Tissue Repair 2012; 5: S20.","journal-title":"Fibrogenesis Tissue Repair"},{"key":"BFleu2017220_CR4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1182\/blood-2015-07-607952","volume":"127","author":"E Bianchi","year":"2016","unstructured":"Bianchi E, Norfo R, Pennucci V, Zini R, Manfredini R . Genomic landscape of megakaryopoiesis and platelet function defects. Blood 2016; 127: 1249\u20131259.","journal-title":"Blood"},{"key":"BFleu2017220_CR5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa1412098","volume":"372","author":"CA Ortmann","year":"2015","unstructured":"Ortmann CA, Kent DG, Nangalia J, Silber Y, Wedge DC, Grinfeld J et al. Effect of mutation order on myeloproliferative neoplasms. N Engl J Med 2015; 372: 601\u2013612.","journal-title":"N Engl J Med"},{"key":"BFleu2017220_CR6","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","volume":"123","author":"P Lundberg","year":"2014","unstructured":"Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I et al. Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 2014; 123: 2220\u20132228.","journal-title":"Blood"},{"key":"BFleu2017220_CR7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/leu.2013.302","volume":"28","author":"E Tenedini","year":"2014","unstructured":"Tenedini E, Bernardis I, Artusi V, Artuso L, Roncaglia E, Guglielmelli P et al. Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. Leukemia 2014; 28: 1052\u20131059.","journal-title":"Leukemia"},{"key":"BFleu2017220_CR8","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1182\/blood-2013-12-544197","volume":"124","author":"R Norfo","year":"2014","unstructured":"Norfo R, Zini R, Pennucci V, Bianchi E, Salati S, Guglielmelli P et al. miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155\/JARID2 axis in abnormal megakaryopoiesis. Blood 2014; 124: e21\u2013e32.","journal-title":"Blood"},{"key":"BFleu2017220_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jmb.2007.11.074","volume":"376","author":"V Blank","year":"2008","unstructured":"Blank V . Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators? J Mol Biol 2008; 376: 913\u2013925.","journal-title":"J Mol Biol"},{"key":"BFleu2017220_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrc2460","volume":"8","author":"A Eychene","year":"2008","unstructured":"Eychene A, Rocques N, Pouponnot C . A new MAFia in cancer. Nat Rev Cancer 2008; 8: 683\u2013693.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2017220_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1535-6108(04)00019-4","volume":"5","author":"EM Hurt","year":"2004","unstructured":"Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T et al. Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell 2004; 5: 191\u2013199.","journal-title":"Cancer Cell"},{"issue":"5","key":"BFleu2017220_CR12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1165\/rcmb.2012-0004OC","volume":"47","author":"Nikos Oikonomou","year":"2012","unstructured":"Oikonomou N, Mouratis MA, Tzouvelekis A, Kaffe E, Valavanis C, Vilaras G et al. Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Cell Mol Biol 47: 566\u2013574.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"BFleu2017220_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jhep.2008.03.020","volume":"49","author":"L Schwettmann","year":"2008","unstructured":"Schwettmann L, Wehmeier M, Jokovic D, Aleksandrova K, Brand K, Manns MP et al. Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases. J Hepatol 2008; 49: 243\u2013250.","journal-title":"J Hepatol"},{"key":"BFleu2017220_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIRCRESAHA.111.243212","volume":"110","author":"PE Kolattukudy","year":"2012","unstructured":"Kolattukudy PE, Niu J . Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1\/CCR2 pathway. Circ Res 2012; 110: 174\u2013189.","journal-title":"Circ Res"},{"key":"BFleu2017220_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","volume":"13","author":"P Menten","year":"2002","unstructured":"Menten P, Wuyts A, Van Damme J . Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002; 13: 455\u2013481.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFleu2017220_CR16","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/cdd.2015.30","volume":"22","author":"E Bianchi","year":"2015","unstructured":"Bianchi E, Bulgarelli J, Ruberti S, Rontauroli S, Sacchi G, Norfo R et al. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF. Cell Death Differ 2015; 22: 1906\u20131921.","journal-title":"Cell Death Differ"},{"key":"BFleu2017220_CR17","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood.V94.5.1578","volume":"94","author":"SP Hegde","year":"1999","unstructured":"Hegde SP, Zhao J, Ashmun RA, Shapiro LH . c-Maf induces monocytic differentiation and apoptosis in bipotent myeloid progenitors. Blood 1999; 94: 1578\u20131589.","journal-title":"Blood"},{"key":"BFleu2017220_CR18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/nm.3995","volume":"21","author":"QJ Wen","year":"2015","unstructured":"Wen QJ, Yang Q, Goldenson B, Malinge S, Lasho T, Schneider RK et al. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. Nat Med 2015; 21: 1473\u20131480.","journal-title":"Nat Med"},{"key":"BFleu2017220_CR19","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4049\/jimmunol.153.6.2819","volume":"153","author":"P Rameshwar","year":"1994","unstructured":"Rameshwar P, Denny TN, Stein D, Gascon P . Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. Potential role for interleukin-1 and TGF-beta. J Immunol 1994; 153: 2819\u20132830.","journal-title":"J Immunol"},{"key":"BFleu2017220_CR20","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.4049\/jimmunol.165.4.2271","volume":"165","author":"P Rameshwar","year":"2000","unstructured":"Rameshwar P, Narayanan R, Qian J, Denny TN, Colon C, Gascon P . NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis. J Immunol 2000; 165: 2271\u20132277.","journal-title":"J Immunol"},{"key":"BFleu2017220_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1182\/blood-2006-10-054502","volume":"110","author":"O Wagner-Ballon","year":"2007","unstructured":"Wagner-Ballon O, Pisani DF, Gastinne T, Tulliez M, Chaligne R, Lacout C et al. Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice. Blood 2007; 110: 345\u2013353.","journal-title":"Blood"},{"key":"BFleu2017220_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/leu.2016.12","volume":"30","author":"S Koschmieder","year":"2016","unstructured":"Koschmieder S, Mughal TI, Hasselbalch HC, Barosi G, Valent P, Kiladjian JJ et al. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both. Leukemia 2016; 30: 1018\u20131024.","journal-title":"Leukemia"},{"key":"BFleu2017220_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cytogfr.2013.01.004","volume":"24","author":"HC Hasselbalch","year":"2013","unstructured":"Hasselbalch HC . The role of cytokines in the initiation and progression of myelofibrosis. Cytokine Growth Factor Rev 2013; 24: 133\u2013145.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFleu2017220_CR24","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","volume":"29","author":"A Tefferi","year":"2011","unstructured":"Tefferi A, Vaidya R, Caramazza D, Finke C, Lasho T, Pardanani A . Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. J Clin Oncol 2011; 29: 1356\u20131363.","journal-title":"J Clin Oncol"},{"issue":"12","key":"BFleu2017220_CR25","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","volume":"363","author":"Srdan Verstovsek","year":"2010","unstructured":"Verstovsek S, Kantarjian H, Mesa RA, Pardanani AD, Cortes-Franco J, Thomas DA et al. Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. N Engl J Med 363: 1117\u20131127.","journal-title":"New England Journal of Medicine"},{"key":"BFleu2017220_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ajh.21972","volume":"86","author":"A Pardanani","year":"2011","unstructured":"Pardanani A, Begna K, Finke C, Lasho T, Tefferi A . Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis. Am J Hematol 2011; 86: 343\u2013345.","journal-title":"Am J Hematol"},{"key":"BFleu2017220_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1034\/j.1600-0609.2002.01732.x","volume":"69","author":"MK Jensen","year":"2002","unstructured":"Jensen MK, Riisbro R, de Nully Brown P, Brunner N, Hasselbalch HC . Elevated soluble urokinase plasminogen activator receptor in plasma from patients with idiopathic myelofibrosis or polycythaemia vera. Eur J Haematol 2002; 69: 43\u201349.","journal-title":"Eur J Haematol"},{"key":"BFleu2017220_CR28","first-page":"119","volume":"2","author":"SM Koopmans","year":"2012","unstructured":"Koopmans SM, Bot FJ, Schouten HC, Janssen J, van Marion AM . The involvement of Galectins in the modulation of the JAK\/STAT pathway in myeloproliferative neoplasia. Am J Blood Res 2012; 2: 119\u2013127.","journal-title":"Am J Blood Res"},{"key":"BFleu2017220_CR29","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1136\/jclinpath-2016-203948","volume":"69","author":"LG Moura","year":"2016","unstructured":"Moura LG, Tognon R, Nunes NS, Rodrigues LC, Ferreira AF, Kashima S et al. Different expression patterns of LGALS1 and LGALS3 in polycythemia vera, essential thrombocythemia and primary myelofibrosis. J Clin Pathol 2016; 69: 926\u2013929.","journal-title":"J Clin Pathol"},{"key":"BFleu2017220_CR30","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1126\/science.1062960","volume":"294","author":"D Chabas","year":"2001","unstructured":"Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001; 294: 1731\u20131735.","journal-title":"Science"},{"key":"BFleu2017220_CR31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2478\/s13380-012-0028-7","volume":"3","author":"A Brown","year":"2012","unstructured":"Brown A . Osteopontin: a key link between immunity, inflammation and the central nervous system. Transl Neurosci 2012; 3: 288\u2013293.","journal-title":"Transl Neurosci"},{"key":"BFleu2017220_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1124\/jpet.114.218370","volume":"351","author":"LC Li","year":"2014","unstructured":"Li LC, Li J, Gao J . Functions of galectin-3 and its role in fibrotic diseases. J Pharmacol Exp Ther 2014; 351: 336\u2013343.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFleu2017220_CR33","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.leukres.2012.10.020","volume":"37","author":"HC Hasselbalch","year":"2013","unstructured":"Hasselbalch HC . Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development? Leuk Res 2013; 37: 214\u2013220.","journal-title":"Leuk Res"},{"key":"BFleu2017220_CR34","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","volume":"119","author":"HC Hasselbalch","year":"2012","unstructured":"Hasselbalch HC . Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood 2012; 119: 3219\u20133225.","journal-title":"Blood"},{"key":"BFleu2017220_CR35","doi-asserted-by":"publisher","first-page":"e0158156","DOI":"10.1371\/journal.pone.0158156","volume":"11","author":"E Lefebvre","year":"2016","unstructured":"Lefebvre E, Moyle G, Reshef R, Richman LP, Thompson M, Hong F et al. Antifibrotic effects of the dual CCR2\/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis. PLoS One 2016; 11: e0158156.","journal-title":"PLoS One"},{"key":"BFleu2017220_CR36","doi-asserted-by":"publisher","first-page":"e21381","DOI":"10.1371\/journal.pone.0021381","volume":"6","author":"HW Zimmermann","year":"2011","unstructured":"Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One 2011; 6: e21381.","journal-title":"PLoS One"},{"key":"BFleu2017220_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/labinvest.2013.3","volume":"93","author":"TK Tan","year":"2013","unstructured":"Tan TK, Zheng G, Hsu TT, Lee SR, Zhang J, Zhao Y et al. Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage. Lab Invest 2013; 93: 434\u2013449.","journal-title":"Lab Invest"},{"key":"BFleu2017220_CR38","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/gutjnl-2015-310752","volume":"66","author":"E Arriazu","year":"2016","unstructured":"Arriazu E, Ge X, Leung TM, Magdaleno F, Lopategi A, Lu Y et al. Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury. Gut 2016.;66: 1123\u20131137.","journal-title":"Gut"},{"key":"BFleu2017220_CR39","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1073\/pnas.0511167103","volume":"103","author":"NC Henderson","year":"2006","unstructured":"Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 2006; 103: 5060\u20135065.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017220_CR40","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A . European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005; 90: 1128\u20131132.","journal-title":"Haematologica"},{"key":"BFleu2017220_CR41","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1182\/blood-2017-01-761999","volume":"129","author":"P Guglielmelli","year":"2017","unstructured":"Guglielmelli P, Pacilli A, Rotunno G, Rumi E, Rosti V, Delaini F et al. Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis. Blood 2017; 129: 3227\u20133236.","journal-title":"Blood"},{"key":"BFleu2017220_CR42","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1182\/blood-2015-11-681932","volume":"127","author":"I Chachoua","year":"2016","unstructured":"Chachoua I, Pecquet C, El-Khoury M, Nivarthi H, Albu RI, Marty C et al. Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants. Blood 2016; 127: 1325\u20131335.","journal-title":"Blood"},{"key":"BFleu2017220_CR43","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1182\/blood-2015-11-679571","volume":"127","author":"C Marty","year":"2016","unstructured":"Marty C, Pecquet C, Nivarthi H, El-Khoury M, Chachoua I, Tulliez M et al. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis. Blood 2016; 127: 1317\u20131324.","journal-title":"Blood"},{"key":"BFleu2017220_CR44","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.4049\/jimmunol.1002354","volume":"187","author":"A Rani","year":"2011","unstructured":"Rani A, Afzali B, Kelly A, Tewolde-Berhan L, Hackett M, Kanhere AS et al. IL-2 regulates expression of C-MAF in human CD4 T cells. J Immunol 2011; 187: 3721\u20133729.","journal-title":"J Immunol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2017220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2017220","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/leu.2017.220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/leu2017220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T12:17:11Z","timestamp":1692879431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2017220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,12]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFleu2017220"],"URL":"https:\/\/doi.org\/10.1038\/leu.2017.220","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,12]]},"assertion":[{"value":"28 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}